Loading
Latest filing published 07 Jan 2022 for Virios Therapeutics, Inc., €21k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Abel De La Rosa has a single filing on record, published on 7 January 2022: an open-market purchase of €21k in Dogwood Therapeutics, Inc. One trade is not enough to describe a pattern. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration